MPP7 inhibitors belong to a distinct chemical class of compounds known for their role in modulating cellular processes by targeting the MPP7 protein. MPP7, or Membrane Protein, Palmitoylated 7, is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. These proteins are essential for cell-to-cell communication and the organization of specialized membrane structures, such as tight junctions and adherens junctions, which are crucial for maintaining tissue integrity and cell polarity. MPP7, in particular, plays a pivotal role in anchoring transmembrane proteins and cytoskeletal elements to these junctional complexes, thereby ensuring cell stability and tissue function.
MPP7 inhibitors are designed to interfere with the function of the MPP7 protein by binding to specific sites on the protein's structure, often at the interface between the protein and its binding partners. By doing so, they disrupt the normal protein-protein interactions that MPP7 mediates, leading to altered junctional organization and cellular behavior. These inhibitors may function as valuable research tools, aiding scientists in elucidating the intricate mechanisms of cell adhesion, polarity, and signaling.
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ruboxistaurin | 169939-94-0 | sc-507364 | 25 mg | $1080.00 | ||
A specific inhibitor of protein kinase Cβ (PKCβ), which can affect signaling pathways that MPP7 may be associated with, particularly in membrane trafficking. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A potent and broad-spectrum PKC inhibitor, which could impact the activity of MPP7 by modulating the cellular signaling pathways involving PKC isoforms. | ||||||